LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

World’s First Portable Fingerprint Drug Test Launched

By LabMedica International staff writers
Posted on 13 Sep 2017
Image: The fingerprint sample collection cartridge and the portable Reader 1000 analysis unit for drug screening (Photo courtesy of Intelligent Fingerprinting).
Image: The fingerprint sample collection cartridge and the portable Reader 1000 analysis unit for drug screening (Photo courtesy of Intelligent Fingerprinting).
The world’s first portable fingerprint-based drug screening system has been launched and is available now. The revolutionary system is hygienic and easy-to-use, collecting fingerprint samples in just five seconds and delivering simultaneous screening results in less than ten minutes for the four main drug groups: cocaine, opiates, cannabis and amphetamines.

Initial applications for the system include support for drug testing programs within drug rehabilitation, workplace and criminal justice arenas. Organizations using the new system, which have previously been reliant on collecting saliva and urine samples for drug screening, will benefit from the simplicity and improved hygiene of fingerprint drug tests. Those being tested appreciate the system’s dignified and non-invasive collection method.

The screening system is being launched by Intelligent Fingerprinting (Cambridge, UK). The technology which consists of a fingerprint sample collection cartridge and the portable Reader 1000 analysis unit works by analyzing the tiny traces of sweat contained in a fingerprint to detect drugs and drug metabolites. The four drug groups detected by Drug Screening Cartridge cover the majority of mainstream drug misuse, ensuring that the company’s new drug testing system can support a broad range of drug screening requirements immediately. Collecting a fingerprint sweat sample on the cartridge takes just five seconds. The cartridge is then inserted into a reader that analyses the fingerprint sweat to provide a positive or negative result for each drug in the test in less than 10 minutes.

Jerry Walker, PhD, CEO of Intelligent Fingerprinting, said, “Our portable fingerprint drug test means that organizations can now screen for drug use almost anywhere at any time. It only takes a few seconds to collect a fingerprint for analysis, and our revolutionary technology offers a much more hygienic and dignified means of testing compared with conventional drug tests that require bio-hazardous samples such as urine or saliva. Following successful UK market trials and validation, it’s clear that fingerprint samples are not only much easier to collect and process, but also deliver when it comes to the rigorous analysis required for drug use diagnostics.”

Related Links:
Intelligent Fingerprinting

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more